Blue Horseshoe Stocks: Wrapping Up an Awesome Short Week

Magnum Hunter Resources Corp. MHRC

We really couldn’t have laid things out more plainly on Wednesday morning with respect to MHRC. We mentioned that we’d followed the stock all the way from our initial alert on 11/16 from a low of .021 to Tuesday’s high of .074 for a total increase of 252%

We then made it a point to remind our readers that there were still gaps to the upside to fill on the chart, which created the real possibility for further gains. The first gap we identified was from .08-.15 and sure enough, MHRC rose to meet the challenge, nearly filling that gap in its entirety.

The stock began from a morning low of .065 and reached as high as .146, which worked out to an intraday move of 125% and brought our overall observed range (.021-.146) to a mammoth 595%

We still need to keep a close eye on MHRC moving forward. The stock closed with strength at .137 on heavy volume, retaining its momentum-play status.


AgriEuro Corp. EURI

EURI was another momentum mover that up until Wednesday’s report had already shown us a 400% swing to the upside, and it too made a sizable intraday run leading into the holiday break.

The stock traded in a daily range from 1.15 to 1.69 giving traders a shot at modest yet solid intraday profits of 47%

We may look to cut-and-run from this point, as EURI has just been relegated to Caveat Emptor status by OTC Markets.


The Bon-Ton Stores, Inc. BONT

We’ve had success tracking BONT in the past, and this week has been a case of history repeating. We executed a textbook bottom bounce call on BONT, tagging it on Monday before observing a low of 1.25, and both Tuesday and Wednesday’s sessions produced bigtime advances of the chart.

It led to a high of 2.49 Wednesday, (+99%) leaving us just one percent shy of a perfect double-bagger on the week.



Pfizer, Inc. PFE – Options

Despite the recent uproar of excellent calls on various stocks, we didn’t want to break for the holiday without submitting a quick options-trading idea, and the one we identified was PFE Weekly $31-32.50 Calls, based on the premarket activity we were observing Wednesday morning.

Significant intraday spikes occurred in each set of contracts within that range, including a pair of four-baggers!

$31 Calls – Trading Range: 1.13-1.92  – Max Gain: 70%
$31.50 Calls – Trading Range: .62-1.60  – Max Gain: 158%
$32 Calls – Trading Range: .24-1.20 – Max Gain: 400%
$32.50 Calls – Trading Range: .13-.66 – Max Gain: 408%

If the bullish activity continues along a similar trend during today’s short session, we may look for quick-strike opportunities in a higher strike range. We’ll radar the PFE Weekly $32-33.50 Calls, but just remember that trading ceases at 1PM Eastern today, at which time all weekly options will expire! 


Extended Watchlist:
DBMM, FDBL, HPTG, IFCR, LTNC, EFUT, KBIO, AEZS

Blue Horseshoe Stocks: NYMX Update, LTNC & More

Nymox Pharmaceutical Corp. NYMX

We certainly hope our readers read over yesterday’s morning report thoroughly, because it would mean that people caught our closing note on NYMX in the extended watchlist. We mentioned the big gap-down on the stock, and that we’d be on the lookout for a reversal.

It didn’t take any time at all for NYMX to behave according to our suspicions; it opened at a low of .59 and immediately began its recovery, which lasted for a good portion of the day and culminated in a high of 1.03. Big congratulations are in order for anyone that took advantage of that 74% intraday rip.

The huge gap-down was apparently caused from a knee-jerk reaction to Sunday’s announcement that the company’s prostate cancer treatment (NX-1207) failed to meet primary efficacy endpoints in Phase 3 studies.

It’s fair to mention that prior to yesterday’s session, NYMX was trading at a base level just below $5 (50DMA of 4.77) and yesterday’s bottom-bounce carried it back up to a mere fraction of that level, so it will be interesting to see how much of its lost ground could potentially be recovered in coming sessions.


Labor Smart Inc. LTNC

We caught LTNC on a routine news scan this morning, and we really like what we learned from a quick glance at the PR. LTNC announced that its October revenues set a company record ($2.7M), contributed to a 23-month streak of year-over-year increases, and brought total revenue for 2014 over the $20M-mark.

Those highlights are substantial enough to have us put LTNC on our radar moving forward. A company exhibiting growth patterns like these is certainly worth watching.

The chart is also coming off of a relative bottom, so it could be that we’ve stumbled across LTNC at just the right time.


Extended Watchlist:
CDTI, CDVI, ODP, VSR, MWW, FCEL

Get Our FREE Daily Reports!